Evidence map›Paper›PMID 22990219›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2013

Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence.

Kenneth A Perkins, Joshua L Karelitz, Nancy C Jao

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 1 synthesis or guideline pooled it, 191 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Combined Smoking Cessation and Alcohol Abstinence Treatment for People Experiencing Homelessness: A Randomized Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  5. Trial
  6. Approach Bias and Tobacco Craving as Mechanisms of the Effect of Approach Bias Retraining on Smoking Cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  7. Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  8. Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2024
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. A novel stress-based intervention reduces cigarette use in non-treatment seeking smokers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  14. Trial
  15. Trial
  16. Trial
  17. Randomized controlled trial testing a video-text tobacco cessation intervention among economically disadvantaged African American adults.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2021
    Trial
  18. How Financial Incentives Increase Smoking Cessation: A Two-Level Path Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  19. Trial
  20. Exercise for Smoking Cessation in Postmenopausal Women: A Randomized, Controlled Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kenneth A PerkinsDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15213, USA. perkinska@upmc.edu
Joshua L Karelitz
Nancy C Jao
University of Pittsburgh · US

Funding

Neuroimaging Abstinence and Medication ResponseP50CA143187 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BALDWIN, DONALD A · 2009 to 2013
$8.6M
Reinforcement-enhancing effects of nicotineR21DA031218 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PERKINS, KENNETH ALAN · 2011 to 2012
$417k
NCI NIH HHS CA143187NCI NIH HHS P50 CA143187NIDA NIH HHS DA031218
6 · The paper itself

Abstract

introductionSmoking cessation is typically verified biochemically by expired-air carbon monoxide (CO) levels below 9 ppm (i.e., ≤8 ppm), but this CO criterion may lead many who have smoked within 24hr to be misclassified as abstinent.

methodsAdult dependent smokers (N = 261; 124 men, 137 women) prospectively recorded each cigarette smoked and provided CO on five consecutive days during each of two short-term attempts to quit smoking. Participants were those recruited for crossover tests of the effects of placebo versus medication (nicotine patch or varenicline) on the ability to initiate 24-hr abstinence. All had either a high or low interest in permanently quitting smoking soon (within 3 months) and were randomized to the presence or absence of daily ($12) monetary reinforcement of abstinence.

resultsTotal accuracy of sensitivity to detect smoking (83%) plus specificity to verify abstinence (87%) was optimal at a CO criterion for abstinence below 5 ppm (≤4 ppm), compared with below 9 ppm (sensitivity of 60%, specificity of 97%). Overall CO detection of sensitivity and specificity was higher in those with high versus low quit interest, but reinforcement of abstinence made no difference.

conclusionsResults indicate a CO criterion half that used in most clinical research may optimally validate 24-hr cessation and reduce misclassification of smokers as "abstinent."

Indexed as

Smoking PreventionAdultBenzazepinesCarbon MonoxideCross-Over StudiesFemaleHumansMaleNicotinic AgonistsProspective StudiesQuinoxalinesRewardSensitivity and SpecificitySmoking CessationTime FactorsTobacco ProductsBenzazepinesCarbon MonoxideNicotinic AgonistsQuinoxalinesVarenicline

Identifiers

PMID22990219
PMCPMC3733388
OpenAlexW2163364964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.